K

Boyu Capital logo

Boyu Capital

Crunchbase
Pitchbook
Crunchbase

Deals on record

1

Common Fundraising Type

Series A

Timberlyne Therapeutics logo
Timberlyne Therapeutics

Biopharmaceutical • Clinical-stage

Venrock Healthcare Capital Partners logo
Lilly Asia Ventures logo
Braidwell logo
Boyu Capital logo

Timberlyne Therapeutics is a biopharmaceutical company developing novel therapies for autoimmune disorders, focusing on advancing a monoclonal antibody targeting CD38.

Series A
$180M
01/10/2025
Article